UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study

American journal of kidney diseases, 2018-11, Vol.72 (5), p.653-661

2018

Volltextzugriff (PDF)

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

American journal of kidney diseases, 2020-01, Vol.75 (1), p.84-104

2020

Volltextzugriff (PDF)

Abstract 2332 Small GTPase Arl4A attenuates EGFR degradation by binding to the ESCRT-II-complex

The Journal of biological chemistry, 2024-03, Vol.300 (3), p.106716, Article 106716

2024

Volltextzugriff (PDF)

Abstract 2245 Discovery and functional characterization of potential biomarkers for wild-type EGFR lung adenocarcinoma via super-SILAC-based quantitative tissue proteomic analysis

The Journal of biological chemistry, 2024-03, Vol.300 (3), p.106659, Article 106659

2024

Volltextzugriff (PDF)

Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET

The Journal of biological chemistry, 2021-01, Vol.296, p.100641-100641, Article 100641

2021

Volltextzugriff (PDF)

Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells

Cell cycle (Georgetown, Tex.), 2015-02, Vol.14 (4), p.648-655

2015

Volltextzugriff (PDF)

Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study

American journal of kidney diseases, 2021-01, Vol.77 (1), p.56-73.e1

2021

Volltextzugriff (PDF)

EGFR inhibition in EGFR‐mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment

Cancer science, 2023-04, Vol.114 (4), p.1270-1283

2023

Volltextzugriff (PDF)

Collagen type I induces EGFR‐TKI resistance in EGFR‐mutated cancer cells by mTOR activation through Akt‐independent pathway

Cancer science, 2018-06, Vol.109 (6), p.2063-2073

2018

Volltextzugriff (PDF)

Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial

American journal of kidney diseases, 2018-12, Vol.72 (6), p.798-810

2018

Volltextzugriff (PDF)

Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma

The Journal of biological chemistry, 2023-06, Vol.299 (6), p.104814-104814, Article 104814

2023

Volltextzugriff (PDF)

Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma

Cancer biology & therapy, 2016-03, Vol.17 (3), p.237-245

2016

Volltextzugriff (PDF)

CKD Progression From the Time of Estimated GFR-Based Waitlist Eligibility and Racial Disparities in Transplant Access

American journal of kidney diseases, 2022-06, Vol.79 (6), p.841-848.e1

2022

Volltextzugriff (PDF)

Real‐world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi‐center study

Cancer science, 2023-06, Vol.114 (6), p.2552-2559

2023

Volltextzugriff (PDF)

Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study

American journal of kidney diseases, 2022-01, Vol.79 (1), p.36-44.e1

2022

Volltextzugriff (PDF)

Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1

American journal of kidney diseases, 2022-09, Vol.80 (3), p.373-382

2022

Volltextzugriff (PDF)

Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants

American journal of kidney diseases, 2021-09, Vol.78 (3), p.361-368.e1

2021

Volltextzugriff (PDF)

GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration

American journal of kidney diseases, 2014-12, Vol.64 (6), p.821-835

2014

Volltextzugriff (PDF)

Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes

The FASEB journal, 2017-08, Vol.31 (8), p.3412-3424

2017

Volltextzugriff (PDF)

Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT

American journal of kidney diseases, 2019-01, Vol.73 (1), p.21-30

2019

Volltextzugriff (PDF)

Association of Blood Pressure With the Progression of CKD: Findings From KNOW-CKD Study

American journal of kidney diseases, 2021-08, Vol.78 (2), p.236-245

2021

Volltextzugriff (PDF)

Cardiovascular and Kidney Outcomes of Non-Diabetic CKD by Albuminuria Severity: Findings From the CRIC Study

American journal of kidney diseases, 2024-07

2024

Volltextzugriff (PDF)

Utility of KRAS mutation detection using circulating cell‐free DNA from patients with colorectal cancer

Cancer science, 2016-07, Vol.107 (7), p.936-943

2016

Volltextzugriff (PDF)

Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy

American journal of kidney diseases, 2018-01, Vol.71 (1), p.91-101

2018

Volltextzugriff (PDF)

Abstract 1903 Epidermal growth factor receptor interactions with phosphatidylinositol 4,5-bisphosphate

The Journal of biological chemistry, 2024-03, Vol.300 (3), p.106380, Article 106380

2024

Volltextzugriff (PDF)

1 – 25 von 2.200

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancers

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.122)
Mit Volltextzugriff
(1.996)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.993)
Life Sciences & Biomedicine
(1.934)
Humans
(1.631)
Egfr
(1.235)
Oncology
(850)
Female
(813)
Male
(629)
Middle Aged
(554)
Animals
(532)
Aged
(479)
Mutation
(458)
Biological And Medical Sciences
(422)
Medical Sciences
(415)
Cell Line, Tumor
(383)
Adult
(378)
Tumors
(354)
Erbb Receptors - Metabolism
(346)
Erbb Receptors - Genetics
(326)
Receptor, Epidermal Growth Factor - Genetics
(315)
Receptor, Epidermal Growth Factor - Metabolism
(314)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

Abstract 2332 Small GTPase Arl4A attenuates EGFR degradation by binding to the ESCRT-II-complex

Abstract 2245 Discovery and functional characterization of potential biomarkers for wild-type EGFR lung adenocarcinoma via super-SILAC-based quantitative tissue proteomic analysis

Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET

Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells

Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study

EGFR inhibition in EGFR‐mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment

Collagen type I induces EGFR‐TKI resistance in EGFR‐mutated cancer cells by mTOR activation through Akt‐independent pathway

Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial

Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma

Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma

CKD Progression From the Time of Estimated GFR-Based Waitlist Eligibility and Racial Disparities in Transplant Access

Real‐world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi‐center study

Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study

Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1

Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants

GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration

Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes

Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT

Association of Blood Pressure With the Progression of CKD: Findings From KNOW-CKD Study

Cardiovascular and Kidney Outcomes of Non-Diabetic CKD by Albuminuria Severity: Findings From the CRIC Study

Utility of KRAS mutation detection using circulating cell‐free DNA from patients with colorectal cancer

Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy

Abstract 1903 Epidermal growth factor receptor interactions with phosphatidylinositol 4,5-bisphosphate

Aktive Filter

Suchergebnisse filtern